Literature DB >> 26564381

Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial.

Jonathan M Morris1, Christine L Roberts2, Jennifer R Bowen3, Jillian A Patterson2, Diana M Bond2, Charles S Algert2, Jim G Thornton4, Caroline A Crowther5.   

Abstract

BACKGROUND: Preterm pre-labour ruptured membranes close to term is associated with increased risk of neonatal infection, but immediate delivery is associated with risks of prematurity. The balance of risks is unclear. We aimed to establish whether immediate birth in singleton pregnancies with ruptured membranes close to term reduces neonatal infection without increasing other morbidity.
METHODS: The PPROMT trial was a multicentre randomised controlled trial done at 65 centres across 11 countries. Women aged over 16 years with singleton pregnancies and ruptured membranes before the onset of labour between 34 weeks and 36 weeks and 6 days weeks who had no signs of infection were included. Women were randomly assigned (1:1) by a computer-generated randomisation schedule with variable block sizes, stratified by centre, to immediate delivery or expectant management. The primary outcome was the incidence of neonatal sepsis. Secondary infant outcomes included a composite neonatal morbidity and mortality indicator (ie, sepsis, mechanical ventilation ≥24 h, stillbirth, or neonatal death); respiratory distress syndrome; any mechanical ventilation; and duration of stay in a neonatal intensive or special care unit. Secondary maternal outcomes included antepartum or intrapartum haemorrhage, intrapartum fever, postpartum treatment with antibiotics, and mode of delivery. Women and caregivers could not be masked, but those adjudicating on the primary outcome were masked to group allocation. Analyses were by intention to treat. This trial is registered with the International Clinical Trials Registry, number ISRCTN44485060.
FINDINGS: Between May 28, 2004, and June 30, 2013, 1839 women were recruited and randomly assigned: 924 to the immediate birth group and 915 to the expectant management group. One woman in the immediate birth group and three in the expectant group were excluded from the primary analyses. Neonatal sepsis occurred in 23 (2%) of 923 neonates whose mothers were assigned to immediate birth and 29 (3%) of 912 neonates of mothers assigned to expectant management (relative risk [RR] 0·8, 95% CI 0·5-1·3; p=0·37). The composite secondary outcome of neonatal morbidity and mortality occurred in 73 (8%) of 923 neonates of mothers assigned to immediate delivery and 61 (7%) of 911 neonates of mothers assigned to expectant management (RR 1·2, 95% CI 0·9-1·6; p=0·32). However, neonates born to mothers in the immediate delivery group had increased rates of respiratory distress (76 [8%] of 919 vs 47 [5%] of 910, RR 1·6, 95% CI 1·1-2·30; p=0·008) and any mechanical ventilation (114 [12%] of 923 vs 83 [9%] of 912, RR 1·4, 95% CI 1·0-1·8; p=0·02) and spent more time in intensive care (median 4·0 days [IQR 0·0-10·0] vs 2·0 days [0·0-7·0]; p<0·0001) compared with neonates born to mothers in the expectant management group. Compared with women assigned to the immediate delivery group, those assigned to the expectant management group had higher risks of antepartum or intrapartum haemorrhage (RR 0·6, 95% CI 0·4-0·9), intrapartum fever (0·4, 0·2-0·9), and use of postpartum antibiotics (0·8, 0·7-1·0), and longer hospital stay (p<0·0001), but a lower risk of caesarean delivery (RR 1·4, 95% CI 1·2-1·7).
INTERPRETATION: In the absence of overt signs of infection or fetal compromise, a policy of expectant management with appropriate surveillance of maternal and fetal wellbeing should be followed in pregnant women who present with ruptured membranes close to term. FUNDING: Australian National Health and Medical Research Council, the Women's and Children's Hospital Foundation, and The University of Sydney.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26564381     DOI: 10.1016/S0140-6736(15)00724-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

2.  Late preterm prelabor rupture of fetal membranes: fetal inflammatory response and neonatal outcome.

Authors:  Ivana Musilova; Ctirad Andrys; Marcela Drahosova; Barbora Zednikova; Helena Hornychova; Lenka Pliskova; Helena Zemlickova; Bo Jacobsson; Marian Kacerovsky
Journal:  Pediatr Res       Date:  2017-12-20       Impact factor: 3.756

3.  PURLs: Deliver or wait with late preterm membrane rupture?

Authors:  Keri Bergeson; Shailendra Prasad
Journal:  J Fam Pract       Date:  2016-11       Impact factor: 0.493

Review 4.  Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.

Authors:  Diana M Bond; Philippa Middleton; Kate M Levett; David P van der Ham; Caroline A Crowther; Sarah L Buchanan; Jonathan Morris
Journal:  Cochrane Database Syst Rev       Date:  2017-03-03

Review 5.  Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).

Authors:  Philippa Middleton; Emily Shepherd; Vicki Flenady; Rosemary D McBain; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

6.  Neonatal sepsis definitions from randomised clinical trials.

Authors:  Rían Hayes; Jack Hartnett; Gergana Semova; Cian Murray; Katherine Murphy; Leah Carroll; Helena Plapp; Louise Hession; Jonathan O'Toole; Danielle McCollum; Edna Roche; Elinor Jenkins; David Mockler; Tim Hurley; Matthew McGovern; John Allen; Judith Meehan; Frans B Plötz; Tobias Strunk; Willem P de Boode; Richard Polin; James L Wynn; Marina Degtyareva; Helmut Küster; Jan Janota; Eric Giannoni; Luregn J Schlapbach; Fleur M Keij; Irwin K M Reiss; Joseph Bliss; Joyce M Koenig; Mark A Turner; Christopher Gale; Eleanor J Molloy
Journal:  Pediatr Res       Date:  2021-11-06       Impact factor: 3.756

7.  Outcomes in Twins Compared With Singletons Subsequent to Preterm Prelabor Rupture of Membranes.

Authors:  Michal Fishel Bartal; Lynda G Ugwu; William A Grobman; Jennifer L Bailit; Uma M Reddy; Ronald J Wapner; Michael W Varner; John M Thorp; Steve N Caritis; Mona Prasad; Alan T N Tita; George R Saade; Dwight J Rouse
Journal:  Obstet Gynecol       Date:  2021-11-01       Impact factor: 7.661

8.  Antibiotic regimens for late-onset neonatal sepsis.

Authors:  Steven Kwasi Korang; Sanam Safi; Chiara Nava; Gorm Greisen; Munish Gupta; Ulrik Lausten-Thomsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-05-08

9.  Antibiotic regimens for early-onset neonatal sepsis.

Authors:  Steven Kwasi Korang; Sanam Safi; Chiara Nava; Adrienne Gordon; Munish Gupta; Gorm Greisen; Ulrik Lausten-Thomsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17

10.  Increased Oxidative Stress Toxicity and Lowered Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis: Associations with Psychiatric Comorbidities.

Authors:  Michael Maes; Thitiporn Supasitthumrong; Chusak Limotai; Ana Paula Michelin; Andressa Keiko Matsumoto; Laura de Oliveira Semão; João Victor de Lima Pedrão; Estefânia Gastaldello Moreira; Andre F Carvalho; Sunee Sirivichayakul; Décio Sabbatini Barbosa; Buranee Kanchanatawan
Journal:  Mol Neurobiol       Date:  2020-06-09       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.